Pipark-T 1.125 Injection

Piperacillin 1000mg + Tazobactam 125mg Injection

Pipark-T 1.125 Injection is a prescription Piperacillin 1000mg + Tazobactam 125mg Injection used as a broad-spectrum antibiotic for managing serious bacterial infections. It combines Piperacillin, an antibacterial agent, with Tazobactam, a beta-lactamase inhibitor that enhances antibiotic effectiveness. The product is supplied in a single vial packing with an MRP of ₹106.45.

Business Enquiry: Interested in PCD Pharma Franchise, Third-Party Manufacturing, or Ethical Pharma Promotion? Connect with us for quality pharmaceutical business opportunities.

Pipark-T 1.125 Injection – Product Identity

• Brand Entity: Pipark-T 1.125

• Generic Entity: Piperacillin + Tazobactam Injection

• Strength Entity: 1.125 gm Injection

• Composition Entity: Piperacillin 1000mg + Tazobactam 125mg

• Dosage Form: Injectable Antibiotic

• Pack Size: Single Vial

• MRP: ₹106.45

Why is Pipark-T 1.125 Injection Used?

Pipark-T 1.125 Injection is used for treating bacterial infections where broad antibacterial coverage is required.

1. Hospital-Acquired Bacterial Infections

Piperacillin Tazobactam Injection helps manage complex bacterial infections commonly treated in hospital settings.

Key Benefit: Provides broad-spectrum antibacterial activity against susceptible bacteria.

2. Respiratory Infection Management

Used in bacterial infections affecting the lungs, including severe respiratory tract infections.

Key Benefit: Helps control bacterial growth responsible for respiratory infections.

3. Complicated Urinary Tract Infections

Piperacillin 1000mg + Tazobactam 125mg Injection is used for complicated urinary infections caused by bacterial pathogens.

Key Benefit: Supports effective bacterial infection control.

4. Skin and Soft Tissue Infection Treatment

Used for bacterial infections involving wounds, tissues, and skin structures.

Key Benefit: Provides antibacterial protection against infection-causing organisms.

5. Intra-Abdominal Infection Support

Used in certain abdominal bacterial infections requiring injectable antibiotic therapy.

Key Benefit: Helps healthcare professionals manage serious infections.

How Does Pipark-T 1.125 Injection Work?

Pipark-T 1.125 Injection uses a dual-action antibacterial mechanism:

1. Piperacillin Stops Bacterial Cell Wall Formation

Piperacillin 1000mg attacks bacterial cell wall synthesis, weakening bacteria and preventing multiplication.

2. Tazobactam Blocks Bacterial Resistance

Tazobactam 125mg inhibits beta-lactamase enzymes that can reduce antibiotic effectiveness.

3. Combination Therapy Improves Coverage

The Piperacillin + Tazobactam combination provides stronger antibacterial action compared with Piperacillin alone.

4. Helps Control Resistant Bacteria

The formulation improves antibiotic performance against bacteria producing resistance enzymes.

In simple words: Piperacillin destroys bacteria, while Tazobactam protects the antibiotic from bacterial resistance.

Pipark-T 1.125 Injection Dosage Guide

The dosage of Piperacillin Tazobactam 1.125 gm Injection depends on infection severity, patient condition, kidney function, and doctor's recommendation.

1. Individualized Patient Dosage

Doctors decide dosage according to infection type and medical requirements.

2. IV Administration Method

This injection is administered through the intravenous (IV) route by trained healthcare professionals.

3. Treatment Duration

The duration depends on treatment response and infection severity.

4. Kidney-Based Dose Adjustment

Patients with kidney impairment may require dosage modification.

Important Dosage Warning: Never self-administer Piperacillin Tazobactam Injection without medical supervision.

Proper dosage helps achieve effective treatment while reducing antibiotic resistance.

Pipark-T 1.125 Injection Side Effects

Most patients tolerate Piperacillin Tazobactam Injection well, but some reactions may occur.

Common Side Effects

• Nausea – Feeling sick after administration.

• Diarrhea – Temporary digestive disturbance.

• Injection Site Reaction – Pain, redness, or swelling.

• Skin Rash – Mild allergic skin response.

Serious & Rare Side Effects

• Severe Allergy – Breathing difficulty, swelling, or serious reactions.

• Blood Abnormalities – Changes in blood cell counts.

• Liver Changes – Altered liver enzyme levels.

• Severe Diarrhea – Persistent antibiotic-related diarrhea.

Contact a healthcare professional if serious symptoms appear.

Safety Precautions Before Using Pipark-T 1.125 Injection

➜ Allergy Assessment

Patients with a history of penicillin or beta-lactam allergy should inform their doctor.

➜ Kidney Health Monitoring

Kidney function should be evaluated before and during treatment when required.

➜ Medicine Interaction Check

Inform healthcare providers about all ongoing medications.

➜ Pregnancy & Lactation Advice

Medical consultation is recommended before use during pregnancy or breastfeeding.

➜ Complete Antibiotic Therapy

Follow the complete prescribed course to prevent antibiotic resistance.

Build Your Future in Pharma With Pipark-T 1.125 Injection

The demand for quality injectable medicines is increasing, creating promising opportunities for pharma professionals and business entrepreneurs. Pipark-T 1.125 Injection (Piperacillin 1000mg + Tazobactam 125mg Injection) offers a strong addition to the healthcare product portfolio for companies looking to grow through PCD Pharma Franchise, Third-Party Pharma Manufacturing, and Ethical Pharma Marketing solutions.

We believe in creating successful pharma partnerships by combining quality products, dependable supply support, and business growth assistance. Our dedicated approach helps franchise partners, distributors, and healthcare businesses strengthen their market presence with a reliable range of pharmaceutical formulations.

Through our monopoly pharma franchise opportunities and third-party manufacturing services, we support partners with professional guidance, promotional assistance, and scalable solutions. From product development to market expansion, we focus on delivering a complete ecosystem that helps businesses achieve sustainable growth in the pharmaceutical sector.

Take the next step toward pharmaceutical success with a trusted partner. Explore opportunities with Pipark-T 1.125 Injection and unlock growth potential through ethical promotion, quality injectable products, and long-term pharma business collaboration. Connect with us today to start building a stronger healthcare network.

Frequently Asked Questions

1. What is Pipark-T 1.125 Injection?

Pipark-T 1.125 Injection is a combination antibiotic containing Piperacillin 1000mg and Tazobactam 125mg used for bacterial infections under medical supervision.

2. What are the main uses of Piperacillin Tazobactam Injection?

It is used for respiratory infections, urinary tract infections, skin infections, and other serious bacterial infections.

3. What is the strength of Pipark-T 1.125 Injection?

The strength is 1.125 gm, containing Piperacillin 1000mg + Tazobactam 125mg.

4. How is Pipark-T 1.125 Injection given?

It is administered by healthcare professionals through an intravenous route.

5. What is the packing and price of Pipark-T 1.125 Injection?

The product comes in a single-vial pack with an MRP of ₹106.45.